These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17421027)

  • 1. The human immunodeficiency virus epidemic: a race against time for millions and the role of flow cytometry. A Caribbean and resource-constrained country perspective.
    Abayomi A
    Cytometry B Clin Cytom; 2007 Nov; 72(6):478-81. PubMed ID: 17421027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometry as the spearhead for delivering sustainable and versatile laboratory services to HIV-burdened health care systems of the developing world: a Caribbean model.
    Abayomi EA; Landis RC
    Cytometry B Clin Cytom; 2008; 74 Suppl 1():S80-9. PubMed ID: 18228563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S; Antunes OA; Fortunak JM
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV / AIDS in the Caribbean.
    Baldwin K
    Caribb Health; 1999 Apr; 2(1):23, 25. PubMed ID: 12349101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responding to the HIV epidemic in the developing world. Capacity building and technology transfer for monitoring with HAART: a Caribbean experience.
    Abayomi A; Adomakoh N; Adomakoh S
    Afr J Med Med Sci; 2006 Dec; 35 Suppl():19-24. PubMed ID: 18050773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WHO outlines three-pronged attack against AIDS epidemic.
    AIDS Wkly; 2000 Feb; ():17. PubMed ID: 12349444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why and how to monitor the cost and evaluate the cost-effectiveness of HIV services in countries.
    Beck EJ; Santas XM; Delay PR
    AIDS; 2008 Jul; 22 Suppl 1():S75-85. PubMed ID: 18664958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS in the Third World: how to stop the HIV infection?
    De Clercq E
    Verh K Acad Geneeskd Belg; 2007; 69(2):65-80. PubMed ID: 17550059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the "3 by 5" initiative the best approach to tackling the HIV pandemic?
    Kim JY; Ammann A
    PLoS Med; 2004 Nov; 1(2):e37. PubMed ID: 15578107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral therapy and HIV prevention in India: modeling costs and consequences of policy options.
    Over M; Marseille E; Sudhakar K; Gold J; Gupta I; Indrayan A; Hira S; Nagelkerke N; Rao AS; Heywood P
    Sex Transm Dis; 2006 Oct; 33(10 Suppl):S145-52. PubMed ID: 17003679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.
    Bennett DE; Bertagnolio S; Sutherland D; Gilks CF
    Antivir Ther; 2008; 13 Suppl 2():1-13. PubMed ID: 18578063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent costs of HIV/AIDS-related health services in Rwanda: implications for financing.
    Quentin W; König HH; Schmidt JO; Kalk A
    Trop Med Int Health; 2008 Oct; 13(10):1245-56. PubMed ID: 18721185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Caribbean: riding the dark horse of HIV/AIDS towards a brighter future.
    Landis RC
    Cytometry B Clin Cytom; 2007 Mar; 72(2):153-5. PubMed ID: 17285624
    [No Abstract]   [Full Text] [Related]  

  • 15. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
    Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
    Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From PMTCT to a more comprehensive AIDS response for women: a much-needed shift.
    Eyakuze C; Jones DA; Starrs AM; Sorkin N
    Dev World Bioeth; 2008 Apr; 8(1):33-42. PubMed ID: 18315723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of HIV/AIDS on Gross Domestic Product (GDP) in the WHO Africa Region.
    Kirigia JM; Sambo LG; Okorosobo T; Mwabu GM
    Afr J Health Sci; 2002; 9(1-2):27-39. PubMed ID: 17298143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Government funding for HIV not keeping pace with epidemic.
    AIDS Policy Law; 1999 May; 14(9):2. PubMed ID: 11366962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. World Bank proposes $150 million to fight AIDS in Caribbean.
    AIDS Policy Law; 2001 May; 16(9):9. PubMed ID: 11675691
    [No Abstract]   [Full Text] [Related]  

  • 20. The president's fiscal year 2007 initiative for human immunodeficiency virus counseling and testing expansion in the United States: a scenario analysis of its coverage, impact, and cost-effectiveness.
    Holtgrave DR
    J Public Health Manag Pract; 2007; 13(3):239-43. PubMed ID: 17435490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.